UBS Group’s Cenevo, Inc. CVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,321
Closed -$1K 8519
2017
Q4
$1K Buy
+1,321
New +$1.85K ﹤0.01% 7790
2017
Q3
Sell
-1,475
Closed -$9K 8256
2017
Q2
$9K Sell
1,475
-1,801
-55% -$9.4K ﹤0.01% 6879
2017
Q1
$16K Buy
3,276
+3,198
+4,100% +$19.8K ﹤0.01% 6338
2016
Q4
$0 Sell
78
-3,607
-98% -$25.7K ﹤0.01% 8292
2016
Q3
$26K Buy
3,685
+81
+2% +$603 ﹤0.01% 6076
2016
Q2
$24K Buy
+3,604
New +$21K ﹤0.01% 6167
2016
Q1
Sell
-1,095
Closed -$8K 8557
2015
Q4
$8K Buy
1,095
+269
+33% +$3.44K ﹤0.01% 7463
2015
Q3
$12K Buy
826
+487
+144% +$6.89K ﹤0.01% 7166
2015
Q2
$6K Buy
339
+89
+36% +$1.62K ﹤0.01% 7823
2015
Q1
$4K Sell
250
-278
-53% -$4.49K ﹤0.01% 8263
2014
Q4
$9K Buy
+528
New +$8.79K ﹤0.01% 8525

Other funds holding CVO

UBS Group's CVO Position: Q1 2018 in Review

UBS Group sold out of Cenevo, Inc. (CVO) in Q1 2018, closing a stake of 1,321 shares — an estimated $1K sold.

UBS Group first reported a position in CVO in Q4 2014 and held it in 11 quarters. The position peaked at $26K in Q3 2016. 1 fund tracked by Wall St. Rank holds CVO as of Q1 2018.

  • UBS Group reported no remaining Cenevo, Inc. position as of Q1 2018 after selling out during the quarter.
  • UBS Group sold 1,321 Cenevo, Inc. shares in Q1 2018, an estimated $1K.
  • UBS Group first reported a position in Cenevo, Inc. in Q4 2014 and held it in 11 quarters.
  • UBS Group's Cenevo, Inc. position peaked at $26K in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Cenevo, Inc. as of Q1 2018.

Based on UBS Group's 13F filing for Q1 2018, filed 15 May 2018.